Tuesday 7 July 2020
Home      All news      Contact us     
Barcelona - 1 month ago

Spin off Iproteos included in Accure Therapeutics to work on drugs for central nervous system diseases

Accure Therapeutics will develop a series of candidate drugs to treat central nervous system diseases. This will start with three programs on new medicines focused on therapeutic targets from Iproteos, a spin off by the University of Barcelona and the Institute for Research in Biomedicine (IRB Barcelona) and Binoure, a spin off by the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Spanish National Research Council (CSIC). Both Iproteos and Binoure have been integrated to Accure Therapeutics. Further information
 


Latest News
Hashtags:   

Iproteos

 | 

included

 | 

Accure

 | 

Therapeutics

 | 

drugs

 | 

central

 | 

nervous

 | 

system

 | 

diseases

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources